Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · IEX Real-Time Price · USD
9.75
-0.02 (-0.20%)
At close: Jul 19, 2024, 4:00 PM
9.69
-0.06 (-0.62%)
Pre-market: Jul 22, 2024, 7:11 AM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.13 billion as of July 22, 2024. Its market cap has increased by 97.60% in one year.
Market Cap
1.13B
Enterprise Value
930.96M
1-Year Change
97.60%
Ranking
Category
Stock Price
$9.75
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $764.40M to $1.13B, an increase of 47.66%. That is a compound annual growth rate of 9.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 1.13B | 270.19% |
Dec 29, 2023 | 304.90M | -66.19% |
Dec 30, 2022 | 901.70M | -13.56% |
Dec 31, 2021 | 1.04B | -15.02% |
Dec 31, 2020 | 1.23B | 60.57% |
Jan 31, 2020 | 764.40M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Maravai LifeSciences Holdings | 1.15B |
Relay Therapeutics | 1.14B |
Artivion | 1.14B |
Owens & Minor | 1.13B |
Autolus Therapeutics | 1.13B |
Silk Road Medical | 1.08B |
Innoviva | 1.07B |
Ironwood Pharmaceuticals | 1.07B |